All treatments
Treatment
Pluvicto 1 000 MBq/mL solution for injection/infusion clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic confirmatory (Phase III)
Studying Treatments in patients receiving androgen deprivation therapy (ADT) for Metastatic Prostate Cancer: Evaluation of Drug and radiation Efficacy: A 2nd multi-arm multi-stage randomised controlled trial (STAMPEDE2)
This study, called STAMPEDE2, is looking at new treatments for men with prostate cancer that has spread. It compares different treatments, including a drug called Pluvicto, to see if they help men live longer and have a better quality of life.
For: Metastatic hormone sensitive prostate cancerIreland · Germany · Spain - Ongoing, recruitingTherapeutic exploratory (Phase II)
The evaluation of the effectiveness, safety and tolerability of treatment, using a specialized prostate-specific membrane antigen (PSMA) labeled with Lutetium177, in patients with recurrent and/or metastatic adenoid cystic carcinoma originating from the salivary glands - an open, non-commercial clinical trial
This study is looking at a new treatment called Pluvicto for a rare type of cancer called adenoid cystic carcinoma, which starts in the salivary glands. Doctors want to see how safe and effective this special medicine is for patients whose cancer has come back or spread.
For: Adenoid cystic carcinomaPoland